<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="421651" id="root" date="1997-03-05" xml:lang="en">
<title>UK: Glaxo plays down inhaler findings.</title>
<headline>Glaxo plays down inhaler findings.</headline>
<dateline>LONDON 1997-03-05</dateline>
<text>
<p>Glaxo Wellcome Plc on Wednesday played down the significance of research findings that suggested an increased glaucoma risk from elderly asthma suffers taking inhaled steroids over an extended period.</p>
<p>A Glaxo spokesman said the findings, published in the Journal of the American Medical Association, appeared to have done no more than highlight a long-established link between a slightly increased risk of glaucoma and steriod inhalation.</p>
<p>&quot;We are talking about a relatively small number of cases despite widespread use for some 20 years,&quot; the spokesman said.</p>
<p>&quot;As far as we are concerned the study indicates a small increase in the risk of taking high doses over a long period, and it is likely that such patients have had very severe symptoms and their cases have therefore been complicated by taking other treatments.&quot;  </p>
<p>Earlier market talk about the findings, along with an earnings reduction by Goldman Sachs, helped unsettle Glaxo shares ahead of the company's annual results on Thursday. The company is a major supplier of inhaled steroids.</p>
<p>Glaxo shares reached a record 10.63 stg in early trading before retreating to be down 26-1/2p at 10.29-1/2 by 1220 GMT. With other major drug stocks Zeneca Group Plc and SmithKline Beecham Plc also under pressure, dealers said there were signs of profit-taking across the sector.</p>
<p>-- David Holmes, London Newsroom +44 171 542 4367</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="UK">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C21">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="C23">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="GCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
  <code code="GHEA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-05"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-03-05"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-03-05"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="LONDON"/>
<dc element="dc.creator.location.country.name" value="UK"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
